Fridays Review: The Support Package Is the Best We've Seen — The Company Behind It Answers Almost Nothing

What Is Fridays?

Fridays is a telehealth weight-care platform operating as Thrive Health Group Inc from 17322 Murphy Ave, Irvine, California, with a BBB-listed start date of 8 February 2023 and alternate business names JoinFridays.com and Fridays. It says it uses licensed prescribers through OpenLoop Healthcare Partners and holds LegitScript certification.

What genuinely distinguishes it is the support wrapped around the medication. Every plan includes unlimited provider visits, group coaching delivered over Zoom covering nutrition, mental health, movement and support groups, one-to-one coaching with a dietitian and journey support, and access to a fitness app — with no membership, signup or lab fees on top. Most competitors sell a vial and a messaging inbox. This is a genuinely more complete programme, and the mental-health component in particular is relevant for anyone whose eating is bound up with mood or stress.

Pricing is layered and, frankly, confusing. Compounded semaglutide is advertised from $117 to $150/month on an annual plan and $199/month month to month, with a separate annual figure of $249/month paid upfront also appearing. Compounded tirzepatide runs $198 to $240/month on an annual plan and $359/month month to month. Brand-name options are listed too: Ozempic at $1,498/month and Zepbound at $1,828/month month to month, and Wegovy in pill and pen form at $49 for a first month then $98/month with an annual plan. Promotional codes advertise savings of $2,288 and $2,588 on twelve-month supplies.

This review has been substantially revised and downgraded. Our earlier assessment was written in March 2026 from the company's marketing and rated it well on its mental-health-informed positioning. The independent record we have since examined does not support that rating. The BBB gives Thrive Health Group an F, with the stated reason 'Failure to respond to 37 complaint(s) filed against business' out of 43 filed. It is not accredited.

Medications Offered & Pricing

Prices are as published on 6 August 2026 and they are unusually hard to pin down — the same page carries $117, $150, $199 and $249 figures for compounded semaglutide depending on plan and promotion. Screenshot what you are quoted. One line deserves particular scrutiny: brand-name Wegovy at '$49 first month, then $98/month with annual plan' is far below any published direct-to-consumer price for Wegovy that we are aware of, and sits oddly beside Ozempic at $1,498 and Zepbound at $1,828 on the same page. Before ordering on that basis, confirm in writing whether $98 is the medication price or a programme fee with the medication billed separately.

Brand-Name or Compounded?

Fridays sells both compounded and brand-name products. Ozempic, Zepbound and Wegovy are FDA-approved medicines; the compounded semaglutide and tirzepatide are not.

Its disclosure is accurate and appropriately worded: 'Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality.' Naming all three dimensions is better than the vaguer language many competitors use, and it makes no equivalence claim of the kind that drew an FDA warning letter to a competitor in February 2026.

Having both routes in one account is a real practical benefit — if you later gain insurance coverage for Zepbound, you can in principle move without changing provider. The caveat is the cash prices attached: $1,498 for Ozempic and $1,828 for Zepbound are unadjusted retail figures that almost nobody should pay without first exhausting insurance, manufacturer savings programmes and direct-to-consumer manufacturer pricing.

The Consultation Process

Eligibility

• •This is the section that matters most, and it is the reason for much of our rating. Fridays advertises a minimum BMI of 20 and a minimum age of 18.
• •A BMI of 20 sits squarely inside the normal weight range, which runs from 18.5 to 24.9. The established criteria for prescribing weight-loss medication — reflected in the labelling of the approved GLP-1 products themselves and in mainstream clinical guidance — are a BMI of 30 or above, or 27 or above with a weight-related condition such as hypertension, type 2 diabetes or obstructive sleep apnoea. Advertising a threshold of 20 means marketing GLP-1 medication to people at a healthy weight.
• •That is not a technicality. GLP-1 therapy in someone who does not need it carries the same gastrointestinal side effects, the same risk of pancreatitis and gallbladder disease, and the same loss of lean mass — without the metabolic benefit that justifies those risks in someone with obesity. It is also precisely the population in whom appetite-suppressing medication is most likely to interact badly with disordered eating.
• •If you have a BMI in the normal range and are being offered a GLP-1, seek an independent clinical opinion from someone who is not selling it.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive.
• •Clinician judgement is required for anyone with a history of pancreatitis, gallbladder disease, severe gastrointestinal disease including gastroparesis, or diabetic retinopathy.
• •Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — usually worst after a dose increase. Less common but serious risks include pancreatitis, gallbladder disease and dehydration-related kidney injury.
• •Anyone with a history of an eating disorder should approach any appetite-suppressing medication with a clinician who knows that history — and should be especially wary of a provider whose published threshold admits people at a normal weight.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

Medication is shipped monthly with shipping included in the plan price. Shipping delays are a consistent theme in the BBB complaint file, alongside dosing errors. One complainant describes paying $896 for a three-month tirzepatide supply, never receiving it, and being refused a full refund. Track shipments actively and do not let an existing supply run out.

• •Unlimited provider visits included in every plan
• •Group coaching over Zoom covering nutrition, mental health, movement and support groups
• •One-to-one coaching with a dietitian and journey support
• •Fitness app access included
• •No membership, signup or lab fees
• •Both compounded and brand-name GLP-1 options in one account
• •Around 4 stars across more than 4,200 Trustpilot reviews
• •Accurate, complete FDA disclosure on compounded medication
• •Trading since February 2023

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Fridays May Be Best For

• •Very few readers on the current record — the unanswered complaint file and the BMI 20 threshold outweigh the support package
• •Existing customers who are receiving the coaching reliably and want to understand the wider record
• •Anyone who does try it: use the month-to-month plan, pay with a disputable card, and verify every shipment

Limitations

• •The minimum BMI of 20 is the finding we would least want a reader to miss. Approved weight-loss medication is indicated at a BMI of 30 or above, or 27 or above with a weight-related condition. A BMI of 20 is a normal, healthy weight. Advertising that threshold is an invitation to people who have no clinical indication for the drug, and it exposes them to the full side-effect profile — gastrointestinal effects, pancreatitis and gallbladder risk, loss of lean mass — with none of the metabolic benefit that justifies those risks in obesity. It is also precisely the marketing most likely to reach people with disordered eating.
• •The complaint record is the second problem and it is severe. An F from the BBB for failing to respond to 37 of 43 complaints does not describe a company with unhappy customers; it describes one that does not engage with them. When the complaints in question include $896 paid for medication that never arrived and a refund refused, the absence of any escalation route stops being an administrative detail.
• •That combination undercuts the very thing Fridays does best. Unlimited provider visits, group coaching and a dietitian genuinely are the most complete support package in this market — and the mental-health element is exactly what a GLP-1 alone does not provide. But a complainant describing over $1,000 spent with prescriptions 'renewed and shipped without meaningful follow-up' suggests the difference between what is sold and what is delivered can be wide.
• •The pricing is unusually hard to read. Four different figures for compounded semaglutide appear across the same pricing page, and a brand-name Wegovy line at $98/month with an annual plan sits implausibly beside Ozempic at $1,498 on that same page. We could not resolve what the $98 actually covers. Get it in writing before ordering.
• •In fairness: the FDA disclosure is accurate and unhedged, the no-fees structure is clean, brand-name options are genuinely available, and more than 4,200 Trustpilot reviewers average around four stars — many people evidently get the programme they paid for. Our rating reflects what happens to the ones who do not, and who the marketing is reaching.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

Fridays sells the best support package in this market and we want to say so clearly. Unlimited provider visits, group coaching over Zoom covering nutrition, movement, support groups and mental health, one-to-one dietitian access and a fitness app — with no membership, signup or lab fees — is more genuine programme than any competitor we have reviewed bundles into a GLP-1 subscription. For readers of this site in particular, a provider that treats the psychological side of eating as part of the treatment rather than an afterthought is addressing something medication alone does not.

Two findings make it impossible to recommend anyway. The Better Business Bureau rates operator Thrive Health Group F for failing to respond to 37 of the 43 complaints filed against it — and among those complaints is a customer who paid $896 for tirzepatide that never arrived and was refused a full refund. A company that does not answer its complaints has no escalation route, and the value of unlimited support is theoretical if a complainant can spend $1,000 and describe prescriptions being 'renewed and shipped without meaningful follow-up'.

The second is the published minimum BMI of 20. That is a normal, healthy weight, well below the BMI 30 — or 27 with a weight-related condition — at which weight-loss medication is indicated. Advertising treatment at that threshold reaches people who have nothing to gain from a GLP-1 and everything to lose from its side effects, and it is the marketing most likely to find people with disordered eating.

We rate Fridays 2.0 out of 5, downgraded from our earlier assessment, which was written from the company's marketing in March 2026 without examining the independent record. If the coaching model is what attracts you, a better construction is a cheaper provider with a clean complaint record — CallonDoc at $89/mo or CoreAge Rx at $99/mo — paired with WeightWatchers Core+ at $22/mo for evidence-backed group support. That combination costs less than Fridays and neither half of it has an F rating.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved and have not been evaluated for safety, efficacy or quality. If you have a BMI in the normal range and are being offered weight-loss medication, seek an independent clinical opinion before starting.